InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Gangloff Scott A., Chief Technology Officer. Insider active across 1 company, notably Akero Therapeutics, Inc.. Aggregated, 5 disclosures have been recorded. History available since 16 December 2024. The latest transaction was filed on 15 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
5,088 sharesCommon StockSEC:0001193125-25-312111
5,088 sharesCommon StockSEC:0001193125-25-312111:0
21,263 sharesCommon StockSEC:0001193125-25-312111:1
2,600 shares@ US$19.62100.0% of flowCommon StockSEC:0000950170-25-110352:0
24,300 shares0Common StockSEC:0000950170-24-138138:0
5 of 5 declarations
About Gangloff Scott A.
Scott A. Gangloff is the Chief Technology Officer at Akero Therapeutics, Inc. He oversees the company's technological initiatives, ensuring innovation and process efficiency. His role is crucial for the development of new therapeutic solutions.
